ENTITY
Dr. Reddy's Laboratories

Dr. Reddy's Laboratories (DRRD IN)

161
Analysis
Health CareIndia
Dr. Reddy's Laboratories Limited provides a complete range of pharmaceutical services. The Company manufactures bulk drugs and formulations including verapamil and cephalexin. The Company also manufactures and exports molecules such as norfloxacin, ciprofloxacin, and varieties of semi-synthetic penicillin. The Company markets its products in India and around the world.
more
08 May 2024 21:14

Dr. Reddy's Laboratories (DRRD IN): Q4 Result- Sequentially Weak Quarter; Time to Book Profit

​Dr. Reddy's reported double-digit revenue and profit growth in Q4FY24, mainly driven by North America. Going ahead, growth will be slower on high...

Logo
330 Views
Share
03 Apr 2024 18:57Broker

Dr Reddy’s Laboratories Ltd - Transition from Generic to Niche Company

North America to clock a 7% CAGR from FY24-26E driven by 25 new product launches in the generics segment (either FTFs or in the 1st wave),...

Logo
Sharekhan
240 Views
Share
14 Feb 2024 09:30

Dr. Reddy's Laboratories (DRRD IN): US and Europe Drive Highest Ever Sales in Q3; Profit Surges 11%

​Dr. Reddy's Laboratories achieves record revenue in Q3FY24, driven by volume gains and new launched in U.S. and Europe. The company has recently...

Logo
328 Views
Share
31 Jan 2024 19:59Broker

Dr Reddy’s Laboratories Ltd - Stability in US and Indian Business

The US business reported sales of $410Mn (+5.5% QoQ), led by stable base business of ~$250 Mn QoQ, gRevlimid ~$120 Mn QoQ, and acquisition business...

Logo
229 Views
Share
bearishMankind Pharma
12 Dec 2023 08:34

Mankind Pharma Lock-Up - A US$1.1bn+ Lockup Release

The two pre-IPO investors have launched a block to sell around US$591m worth of Mankind Pharma shares. Since the lockup on the shares expired not...

Logo
601 Views
Share
x